Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 regrading receipt of No Objection Letter received from National Stock Exchange of India Limited in relation to scheme of Amalgamation.
PRIVISCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.6 pts less than Nifty Microcap 250 and 2.6 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Privi Speciality Chemicals Ltd has received a 'no objection' observation letter from the National Stock Exchange (NSE) for a proposed scheme of amalgamation. Under this scheme, Privi Speciality Chemicals (the transferee company) will merge with two wholly-owned subsidiaries — Privi Fine Sciences Private Limited (PFSPL) and Privi Biotechnologies Private Limited (PBPL) — along with their respective shareholders and creditors. The amalgamation is being undertaken under Sections 230 to 232 of the Companies Act, 2013. BSE's observation letter is still awaited, and the scheme remains subject to additional regulatory and statutory approvals before it can be completed.
The NSE clearance is a positive regulatory milestone, bringing the amalgamation a step closer to completion. Pending final NCLT approval, this internal restructuring could streamline operations and consolidate ownership of the subsidiary businesses under the listed entity.